Antiparkinsonian Activity of Hydroalcoholic Extract of Operculina turpethum Roots in Reserpine Induced Parkinsonism in Wistar Rats

B K Supriya; N Prem Kumar; Pravash Gurung; Barsha Bhujel; Dikcha Gupta; A Deekshitha

doi:10.17485/IJST/v16i48.3023

Article

Antiparkinsonian Activity of Hydroalcoholic Extract of Operculina turpethum Roots in Reserpine Induced Parkinsonism in Wistar Rats

VIEWS 122
PDF 34

Indian Journal of Science and Technology

DOI: 10.17485/IJST/v16i48.3023

Year: 2023, Volume: 16, Issue: 48, Pages: 4710-4720

Original Article

Antiparkinsonian Activity of Hydroalcoholic Extract of Operculina turpethum Roots in Reserpine Induced Parkinsonism in Wistar Rats

B K Supriya¹, N Prem Kumar^2*, Pravash Gurung¹, Barsha Bhujel¹, Dikcha Gupta¹, A Deekshitha¹

¹Student, Department of Pharmacology, Krupanidhi College of Pharmacy, Bengaluru, 560035, Karnataka, India
²Professor, Department of Pharmacology, Krupanidhi College of Pharmacy, Bengaluru, 560035, Karnataka, India

*Corresponding Author
Email: [email protected]

Received Date:27 November 2023, Accepted Date:24 December 2023, Published Date:30 December 2023

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Objective: The aim of this study was to examine the effect of Operculina turpethum (Linn.) root extract in attenuating reserpine induced Parkinson’s disease to quench the free radicals produced as a result of the increased oxidative stress in Parkinson disease. Methods: Parkinson’s disease is induced by administration of reserpine (0.1 mg/kg/day, i.p.) in albino rats for 21 days. Simultaneously the rats were pretreated with two doses of hydroalcoholic extract of Operculina turpethum (200mg/kg and 400mg/kg p.o.) daily once for the 21 days. The anti-Parkinson’s effect of the extract was evaluated by assessing various behavioral (motor and non-motor) and biochemical (lipid peroxidation, creatinine, acetylcholine esterase and total protein) parameters as well as histological examination. Findings: Reserpine significantly causes tremor, rigidity, akinesia which were reversed by daily administration of Operculina turpethum root extract that may be attributed to a reduction in the acetylcholine, total protein, and creatine due to multifunctional activity of various phytochemicals present in the Operculina turpethum extract when compared to L-DOPA/C-DOPA group. There was a significant histological improvement in the neuronal degeneration in brain tissue on treatment with Operculina turpethum root extract. The results indicated the protective effect of Operculina turpethum extract against Parkinson’s disease. Novelty: Dopamine replacement and levodopa, two prevalent medications for PD, only exhibit some effects of limited symptomatic relief but cause many severe adverse effects, such as hallucination and involuntary movement. The hydroalcoholic extract of Operculina turpethum roots can be favourable for the development of disease-modifying drugs for Parkinson’s disease.

Keywords: Operculina turpethum; Parkinson’s Disease; Reserpine; Lewy bodies; Neuroprotective

References

Bloem BR, Okun MS, Klein C. Parkinson's disease. The Lancet. 2021;397(10291):2284–2303. Available from: https://doi.org/10.1016/S0140-6736(21)00218-X
Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, et al. Current and projected future economic burden of Parkinson’s disease in the U.S. npj Parkinson's Disease. 2020;6(1):1–9. Available from: https://doi.org/10.1038/s41531-020-0117-1
Armstrong MJ, Okun MS. Diagnosis and Treatment of Parkinson Disease. JAMA. 2020;323(6):548–560. Available from: https://doi.org/10.1001/jama.2019.22360
Balestrino R, Schapira AHV. Parkinson disease. European Journal of Neurology. 2020;27(1):27–42. Available from: https://doi.org/10.1111/ene.14108
Raza C, Anjum R, Shakeel NUA. Parkinson's disease: Mechanisms, translational models and management strategies. Life Sciences. 2019;226:77–90. Available from: https://doi.org/10.1016/j.lfs.2019.03.057
Shukla R. Extraction phytochemical screening of successively extracted Operculina turpethum plant extracts. International Journal of Pharmaceutics & Drug Research. 2019;7(2):79–84. Available from: https://ijpdr.com/show-article/MjEw
Saadullah M, Arif S, Hussain L, Asif M, Khurshid U. Dose Dependent Effects of Breynia cernua Against the Paraquat Induced Parkinsonism like Symptoms in Animals’ Model: In Vitro, In Vivo and Mechanistic Studies. Dose-Response. 2022;20(3):1–16. Available from: https://doi.org/10.1177/15593258221125478
Choudhary N, Prasad SB, Singh A, Khatik GL, Prabhu KS, Mishra V, et al. Phytochemistry and pharmacological potential of Operculina turpethum. Plant Archives. 2020;20(Special Issue):683–692. Available from: https://www.plantarchives.org/SPECIAL%20ISSUE%2020-1/683-692%20(68).pdf
Pingale T, Gupta GL. Classic and evolving animal models in Parkinson's disease. Pharmacology Biochemistry and Behavior. 2020;199:173060. Available from: https://doi.org/10.1016/j.pbb.2020.173060
Luciani KR, Frie JA, Khokhar JY. An Open Source Automated Bar Test for Measuring Catalepsy in Rats. eneuro. 2020;7(3):1–5. Available from: https://doi.org/10.1523/ENEURO.0488-19.2020
Li W, Zhao Q, Wang J, Wang Y, Wen T. Dcf1 deletion presents alterations in gut microbiota of mice similar to Parkinson’s disease. Biochemical and Biophysical Research Communications. 2020;529(4):1137–1144. Available from: https://doi.org/10.1016/j.bbrc.2020.06.150
Ebrahimi-Ghiri M, Shahini F, Zarrindast MR. The effect of URB597, exercise or their combination on the performance of 6-OHDA mouse model of Parkinson disease in the elevated plus maze, tail suspension test and step-down task. Metabolic Brain Disease. 2021;36(8):2579–2588. Available from: https://doi.org/10.1007/s11011-021-00851-z
Ahmed OG, Mahmoud M, Abdelhamid AA. Behavioral Evaluation of rotenone model of Parkinson’s disease in male Wistar rats. Sohag Medical Journal. 2020;24(2):8–14. Available from: https://doi.org/10.21608/smj.2020.21596.1089
Nandagopal A, Khan MAA. Neuroprotective effect of polyherbal formulation in’ Parkinson’s animal model. Asian Journal of Pharmaceutical and Clinical Research. 2020;13(3):121–125. Available from: https://doi.org/10.22159/ajpcr.2020.v13i3.36549
Vecchia DD, Kanazawa LKS, Wendler EK, Hocayen PDAS, Vital MABF, Takahashi RN, et al. Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease. Brain Research Bulletin. 2021;168:63–73. Available from: https://doi.org/10.1016/j.brainresbull.2020.12.011
Goel R, Chaudhary R. Effect of daidzein on Parkinson disease induced by reserpine in rats. Brazilian Journal of Pharmaceutical Sciences. 2020;56:1–7. Available from: https://doi.org/10.1590/s2175-97902019000318388
Avcı B, Günaydın C, Güvenç T, Yavuz CK, Kuruca N, Bilge SS. Idebenone Ameliorates Rotenone-Induced Parkinson’s Disease in Rats Through Decreasing Lipid Peroxidation. Neurochemical Research. 2021;46(3):513–522. Available from: https://doi.org/10.1007/s11064-020-03186-w
Saleem U, Chauhdary Z, Raza Z, Shah S, Rahman MUU, Zaib P, et al. Anti-Parkinson's Activity of Tribulus terrestris via Modulation of AChE, α-Synuclein, TNF-α, and IL-1β. ACS Omega. 2020;5(39):25216–25227. Available from: https://doi.org/10.1021/acsomega.0c03375
Vannur A, Biradar PR, Patil V. Experimental validation of Vitex negundo leaves hydroalcoholic extract for neuroprotection in haloperidol induced parkinson’s disease in rat. Metabolic Brain Disease. 2022;37(2):411–426. Available from: https://doi.org/10.1007/s11011-021-00878-2
Karmakar UK, Akter S, Sheikh S. Phytochemical Screening and Analgesic activity study of different solvent fractions of Aerial parts of Operculina turpethum (L.) Journal of Ayurvedic and Herbal Medicine. 2021;7(3):176–181. Available from: https://www.ayurvedjournal.com/JAHM_202173_02.pdf
Giri MA, Bhalke RD, Prakash KV, Kasture SB. Comparative evaluation of Nardostachys jatamansi and Mucuna pruriens as neuroprotective in Parkinson's disease. Asian Journal of Pharmacy and Pharmacology. 2020;6(3):224–230. Available from: https://ajpp.in/uploaded/p440.pdf
Samur DN, Akçay G, Yıldırım S, Ozkan A, Çeker T, Derin N, et al. Vortioxetine ameliorates motor and cognitive impairments in the rotenoneinduced Parkinson’s disease via targeting TLR2 mediated neuroinflammation. Neuropharmacology. 2022;208:108977. Available from: https://doi.org/10.1016/j.neuropharm.2022.108977
Mishra M, Tomar S, Mishra A. Experimental validation of Psidium guajava and Madhuca indica extracts and fractions for Parkinson’s disease in mice. Journal of Population and Therapeutics and Clinical Pharmacology. 2023;30(18):410–424. Available from: https://doi.org/10.53555/jptcp.v30i18.3093
Swami S, Mughees M, Kauser S, Wajid S. Evaluation of acute oral toxicity of Ipomoea turpethum extract loaded polymeric nanoparticles in Wistar rats. Frontiers in Pharmacology. 2023;14:1–12. Available from: https://doi.org/10.3389/fphar.2023.1086581
Peng S, Zhou Y, Lu M, Wang Q. Review of Herbal Medicines for the Treatment of Depression. Natural Product Communications. 2022;17(11):1–17. Available from: https://doi.org/10.1177/1934578X221139082
Vahedi-Mazdabadi Y, Karimpour-Razkenari E, Akbarzadeh T, Lotfian H, Toushih M, Roshanravan N, et al. Anti-cholinesterase and neuroprotective activities of sweet and bitter apricot kernels (prunus armeniaca L.) Iranian Journal of Pharmaceutical Research: IJPR. 2020;19(4):216–224. Available from: https://doi.org/10.22037/ijpr.2019.15514.13139

Copyright

© 2023 Supriya et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Published By Indian Society for Education and Environment (iSee)